Oxazaphosphorines as biological response modifiers--experimental and clinical perspectives.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D008262:Macrophage Activation / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D051381:Rats
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; C037933:Asta Z 7557; D003520:Cyclophosphamide